首页> 外文期刊>Life Science Journal >Physical Evaluation and In Vitro Bioequivalence Study of Marketed Aspirin Enteric Coated Tablets in KSA
【24h】

Physical Evaluation and In Vitro Bioequivalence Study of Marketed Aspirin Enteric Coated Tablets in KSA

机译:KSA市场阿司匹林肠溶片的物理评估和体外生物等效研究

获取原文
           

摘要

Purpose: The main of this study is to evaluate the in-vitro bio equivalency of enteric coatedAspirin tablets in the Kingdom of Saudi Arabia (KSA). Methods: Two available brands of Aspirin enteric coatedtablets were randomly collected from various pharmacies, and were then coded as A (DISPRIN) and B (JUSPRIN).An innovator Aspirin enteric coated tablet was also procured fromalocal community pharmacy. Pure Aspirin drugwas procured from Sigma-Aldrich. General quality assessment such as weight variation, hardness, friability,disintegration test, and a dissolution study were performed as per USP guidelines. Results: All A and B brandspassed the weight variation test, as no more than two tablets failed, in all cases. The hardness test results for theinnovator, and brands A and B, were recorded as 4.91, 5.25 and 4.58 kg, respectively. The friability test was alsocarried out for the innovator and brands A and B, whereby all experienced weight loss of 0.086%, 0.030% and0.077%, respectively. Although the results of the disintegration test made it clear that the innovator, as well asbrands A and B, did not disintegrate in an acidic medium, all tablets disintegrated in a pH 6.8 buffer solution in19.36, 21.58 and 15.13 minutes, respectively. There were no significant variations in the dissolution profiles or inthe release profiles of the innovator, nor in brands A and B. There was a release of drug in a basic medium withinone hour (90.19%, 82.04% and 87.64%, respectively). Finally similarity factors (f2) were calculated for brands Aand B, which were 72.12% and 88.72%, respectively. Conclusion: On the basis of in-vitro tests, brands A and B areconsidered bioequivalent and interchangeable, while brand B is closer to the innovator in terms of hardness,disintegration and dissolution profile.[Muhammad Hadi Sultan, Md Sarfaraz Alam, Osama A. Madkhali, Md Sajid Ali., Muaid Ahmed Aqeel, RyanIbrahim Gaderi, Abdullah Muhammad Khardali. Physical Evaluation and In Vitro Bioequivalence Study ofMarketed Aspirin Enteric Coated Tablets in KSA. Life Sci J 2020;17(9):1-7]. ISSN: 1097-8135 (Print) / ISSN:2372-613X (Online). http://www.lifesciencesite.com. 1. doi:10.7537/marslsj170920.01.
机译:目的:本研究的主要原因是评估沙特阿拉伯王国(KSA)肠溶纤维素片的体外生物等效。方法:从各种药房中随机收集两种可用品牌的阿司匹林肠涂层,然后被编码为(Disprin)和B(Jusprin)。An Innovator Aspirin肠涂层片也被采购的FromoCal社区药房。从西格玛 - 奥尔德里奇采购的纯阿司匹林药物。根据USP指南,进行一般质量评估,如体重变化,硬度,脆性,崩解试验和溶解研究。结果:所有情况下,所有A和B Brandbass都是重量变异测试,因为在所有情况下,不超过两种平板电脑失败。 Theinnovator和品牌A和B的硬度测试结果分别记录为4.91,5.25和4.58千克。脆性测试为创新者和品牌A和B以及B的途径,其中所有体重减轻分别为0.086%,0.030%和0.077%。虽然崩解试验的结果明确表示创新者,以及As Asband A和B,在酸性介质中没有崩解,但分别在19.36,21.58和15.13分钟中分别在pH 6.8缓冲溶液中崩解的所有片剂。创新者的溶出谱或释放概况没有显着变化,也没有品牌A和B.碱性培养基中的药物释放,分别为期(90.19%,82.04%和87.64%)。最后为品牌AAND B计算相似因素(F2),分别为72.12%和88.72%。结论:在体外测试的基础上,品牌A和B又是生物等效和可互换的,而Brand B在硬度,崩解和溶解概况方面更接近创新者。[穆罕默德·哈迪苏丹,MD Sarfaraz Alam,奥萨马A. Madkhali,MD Sajid Ali。,Muaid Ahmed Aqeel,Ryanibhim Gaderi,Abdullah Muhammad Khardali。 KSA中磁性阿司匹林肠涂层片的物理评价及体外生物等效研究。生命SCI J 2020; 17(9):1-7]。 ISSN:1097-8135(印刷品)/ ISSN:2372-613x(在线)。 http://www.lifesciencesite.com。 1. DOI:10.7537 / MARSLSJ170920.01。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号